Phillips Jack's Form 4/A amendment
AmendedAccelerate Diagnostics, Inc (AXDX) · filed Jul 10, 2023
- Accession no.
- 0001628280-23-024660
- Filed
- Jul 10, 2023
- Trade date
- Jun 26, 2023
- Filing delay
- 14 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Jun 26, 2023
This filing lists 1 derivative transaction. It carries over 3 transactions from the original filing that it did not restate. Open-market sales total $19.4K. It was filed 14 days after the trade.
This amendment restates part of 0001628280-23-023503 (filed Jun 26, 2023). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Phillips JackCIK 0001784805 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 26, 2023 | Common Stock | AGrant or awardAcquired | +3,131,579 | $0.00 | $0 | 3,131,579 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001628280-23-023503 (filed Jun 26, 2023).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 22, 2023 | Common Stock | MOption exerciseAcquired | +62,160 | $0.00F1 | $0 | 563,624 | Direct | |
| Jun 22, 2023 | Common Stock | SSaleDisposed | −27,262 | $0.71 | −$19,356.02 | 536,362 | Direct |
Derivative securities (Table II)
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 22, 2023 | Common Stock | MOption exerciseDisposed | −62,160 | $0.00 | $0 | 0 | Direct |
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F1
The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On June 22, 2020, the reporting person was granted a total of 186,480 RSUs, which vested in equal amounts on each anniversary date, over three years, beginning June 22, 2021 and ending on June 22, 2023.
Referenced by the price of 1 transaction in Table I.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
On June 26, 2023, the reporting person filed a Form 4, which inadvertently reported an incorrect vesting date for the 3,131,579 restricted stock units ("RSUs") granted to the reporting person on June 26, 2023. The RSUs represent a contingent right to receive one share of common stock for each RSU. 626,316 RSUs vest on June 26, 2025, 626,316 RSUs vest on July 10, 2025, 939,474 RSUs vest on June 26, 2026, and 939,473 RSUs vest on July 10, 2026. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.
- F2
Not applicable.